drugset / Trial / NCT04595916
Efficacy and Safety of Polyene Phosphatidylcholine in Treatment of Patients With Acute Drug-induced Liver Injury
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to explore the efficacy and the safety of polyene phosphatidylcholine Injection in patients with acute drug-induced liver injury after 2-4 weeks of treatment.
Timeline
- Start
- 2020-04-04
- Primary completion
- 2020-10-21
- Completion
- 2020-11-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Magnesium Isoglycyrrhizinate | Unknown | 200 mg | — |
| Subject | Polyene Phosphatidylcholine | Small molecule | 930 mg | — |